p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer.

Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
Molecular Cancer Research (Impact Factor: 4.5). 07/2006; 4(6):401-10. DOI: 10.1158/1541-7786.MCR-06-0028
Source: PubMed

ABSTRACT In this study, we did a bioassay employing mice with a dominant-negative p53 mutation (p53(Val135/WT)) to assess whether a germ-line p53 mutation predisposed mice toward the development of squamous cell carcinomas (SCC) in the oral cavity. Treatment of the mouse oral cavity with 4-nitroquinoline-1-oxide produced a 66%, 91%, and 20% tumor incidence in the oral cavity, esophagus, and forestomach/stomach, respectively, in p53(Val135/WT) mice. In contrast, only a 25%, 58%, and 4% tumor incidence was observed in oral cavity, esophagus, and forestomach/stomach, respectively, in wild-type littermates (p53(WT/WT)). The most striking difference between p53(Val135/WT) and p53(WT/WT) mice following the carcinogen treatment was the higher prevalence and more rapid development of SSC in p53(Val135/WT) mice than in wild-type mice. To identify the precise genes or pathways involved in these differences during tumor development, we examined gene expression profiles of 4-nitroquinoline-1-oxide-treated normal tongues as well as tongue SCC in p53(Val135/WT) and p53(WT/WT) mice. Microarray and GenMAPP analysis revealed that dominant-negative p53 ((135)Valp53) affects several cellular processes involved in SCC development. Affected processes included apoptosis and cell cycle arrest pathways, which were modulated in both tumor and normal epithelium. These results showed that reduction of p53-dependent apoptosis and increases in cell proliferation might contribute to the observed increase in oral cavity and gastroesophageal malignancies in p53(Val135/WT) mice as well as to the more rapid growth and progression of tumors.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Model systems are irreplaceable to study cancer. Although the best model system is human cancer in man, research in patients is restricted by ethical and financial restraints. Furthermore, experiments cannot be repeated and patient numbers are limited. Tumor cell cultures are the most versatile system to study cancer cells. They allow for repeated experiments in controlled conditions, are relatively inexpensive and are ideal to study genes, pathways, and tumor response. Mouse models enable to study cancer behavior and carcinogenesis in vivo and many different model systems are available. Apart from xenografts in immune compromised mice, transplantation of oral mice tumors in syngeneic mice, animals developing oral cancer using carcinogen exposure and genetically modified mice can be used. All these models, however, have advantages and limitations that will be discussed in this chapter. KeywordsSquamous cell cancer-Mouse-Model system-Xenograft-Cell culture-Head and neck-Transgenic
    06/2011: pages 191-200;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Metastasis is a complex, highly coordinated series of events in which cells from a primary tumor invade lymphatic and/or blood vessels and spread to regional lymph nodes and/or distant organs, establishing proliferating tumor deposits. Because this process requires the interaction of tumor cells with many types of normal cells, tissues, and systems of an intact organism, in vitro model systems provide very limited information regarding the biology of metastasis. Therefore, in vivo model systems are needed to further our understanding of the metastatic process. Several major types of murine model systems have been most informative and include those in which tumor cells are implanted into tissues or injected into the blood system. Also useful are autochthonous models, in which tumors with metastatic potential are induced at the primary site, in this case, the oral cavity, through treatment of the oral mucosa with chemical carcinogens or by genetically engineering changes in the expression of oncogenes and tumor suppressor genes in the oral epithelia. This chapter summarizes the progress that has been made in the development of mouse models of metastasis in oral cancer and the contributions of these models to our understanding of the biology of oral cancer metastasis.
    11/2009: pages 135-161;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancer is likely caused by alterations in gene structure or expression. Recently, next generation sequencing has documented mutations in 106 head and neck squamous cell cancer genomes, suggesting several new candidate genes. However, it remains difficult to determine which mutations directly contributed to cancer. Here, summarize the animal models which have already validated and may test cancer causing mutations identified by next generation sequencing approaches. We reviewed the existing literature on genetically engineered mouse models and next generation sequencing (NGS), as it relates to animal models of squamous cell cancers of the head and neck (HNSCC) in PubMed. NSG has identified an average of 19 to 130 distinct mutations per HNSCC specimen. While many mutations likely had biological significance, it remains unclear which mutations were essential to, or "drive," carcinogenesis. In contrast, "passenger" mutations also exist that provide no selection advantage. The genes identified by NGS included p53, RAS, Human Papillomavirus oncogenes, as well as novel genes such as NOTCH1, DICER and SYNE1,2. Animal models of HNSCC have already validated some of these common gene mutations identified by NGS. The advent of next generation sequencing will provide new leads to the genetic changes occurring in squamous cell cancers of the head and neck. Animal models will enable us to validate these new leads in order to better elucidate the biology of squamous cell cancers of the head and neck.
    Journal of oral & maxillofacial research. 04/2013; 4(1):e1.